UPDATE: Morgan Stanley Assumes Bristol-Myers Squibb Co. (BMY) at Underweight
Tweet Send to a Friend
(Updated - April 6, 2022 4:54 AM EDT)
Morgan Stanley analyst Terrance Flynn assumes Bristol-Myers Squibb Co. (NYSE: BMY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Terrance Flynn assumes Bristol-Myers Squibb Co. (NYSE: BMY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE